China-based Innoforce Pharmaceuticals raises $96m in Series A round
Innoforce Pharmaceuticals, a Chinese biopharmaceutical innovation and partnership company, has raised CNY625 million ($96 million) in a Series A financing round. The Series A round was co-led by South China Venture Capital (SCVC) and Yanchuang Capital. Existing investor Quan Capital Management, which led the Pre-A financing round, and others, also took part in the funding […]